High materiality8/10
BMO Capital Reiterates Outperform Rating on Amgen (AMGN)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO Capital reiterates outperform; target $400; price $362.45.
- BMO Capital reiterates outperform; target $400; price $362.45.
Key facts
- 01
Target: $400
- 02
Posted price: $362.45
- 03
Analyst firm: BMO Capital
- 04
Analyst: Evan David Seigerman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.